ABL Attended Keystone Symposia on HIV Vaccines

ABL Attended Keystone Symposia on HIV Vaccines

  • Feb 10-15, 2013
  • Keystone, CO

ABL scientists and staff attended the Keystone Symposia on HIV Vaccines in Keystone, Colorado from February 10 to February 15. The HIV Vaccines meeting is part of the Keystone Symposia Global Health Series and is supported by the Bill & Melinda Gates Foundation.

The symposia featured speakers discussing current trends and discoveries in HIV Vaccine research. Some of the topics included:

  • B Cell Development and Signaling
  • Antibody Effector Functions and Env Based Immunogen design
  • Molecular Basis of Antibody Diversification
  • Early Events in B Cell Activation
  • Protective Responses in Animal Models
  • B Cell Repertoire Selection
  • B Cell Responses to Vaccines and HIV
  • Protective Antibody Responses Against HIV
  • MicroRNAs and B Cell Neoplasias
  • Innate Immunity and Stimulation
  • Autoimmunity and Regulatory B Cells